EUTM file information
018688583
ZEPBOUND
April 18, 2022
Trademark Summary
The trademark application ZEPBOUND was filed by Eli Lilly and Company, a U.S. corporation (the "Applicant"). The application was published for oppositions on June 30, 2022, and still open for oppositions.
The application was filed in English (German was selected as the second language).
Goods And Services
- The mark was filed in class 5 with following description of goods:
- Pharmaceutical preparations, namely, pharmaceutical preparations for the treatment, prevention and/or diagnosis of alopecia, Alzheimer's disease, atopic dermatitis, autoimmune diseases and disorders, blood diseases and disorders, bone and skeletal diseases and disorders, cancer, cardiovascular diseases, central nervous system diseases and disorders, cluster headaches, Coronavirus disease, Crohn's disease
- Pharmaceutical preparations, namely, pharmaceutical preparations for the treatment, prevention and/or diagnosis of dementia, dermatological diseases and disorders, diabetes, dyslipidemia, endocrine diseases and disorders, fibromyalgia, gastrointestinal diseases and disorders, headaches, heart failure, inflammation and inflammatory diseases and disorders inflammatory bowel disease, kidney diseases and disorders, liver diseases and disorders, lupus, mental disorders, metabolic diseases and disorders
- Pharmaceutical preparations, namely, pharmaceutical preparations for the treatment, prevention and/or diagnosis of migraines, neurodegenerative diseases and disorders, neurological disorders, obesity, osteoarthritis, pain, Parkinson's disease, Psoriasis, Psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and vascular diseases
- Pharmaceutical preparations.
